BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Mineralys Therapeutics to Announce First Quarter 2025 Financial Results and Host Conference Call on Monday, May 12, 2025

  May 6, 2025

   · 

  1 min read
• Press Releases

  ORIC® Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Updates

  May 6, 2025

   · 

  9 min read
• Press Releases

  Immuneering Reports First Quarter 2025 Financial Results and Provides Business Updates

  May 6, 2025

   · 

  10 min read
• Press Releases

  Carlyle and SK Capital Receive All Required Regulatory Approvals to Complete the Acquisition of bluebird bio

  May 6, 2025

   · 

  11 min read
• Press Releases

  Global First-in-Class AT2R Antagonist TRD205 Advances to Phase II: First Patient Dosed in Chronic Post-Surgical Neuropathic Pain Trial

  May 6, 2025

   · 

  2 min read
• Press Releases

  Thetis Pharmaceuticals Presents New Preclinical and Clinical Data forTP-317 at DDW 2025

  May 6, 2025

   · 

  3 min read
• Press Releases

  Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

  May 6, 2025

   · 

  5 min read
• Press Releases

  Sangamo Therapeutics Announces First Quarter 2025 Earnings Call

  May 6, 2025

   · 

  1 min read
• Press Releases

  Vetter Prioritizes Continuity and Action in its Sustainability Efforts

  May 6, 2025

   · 

  1 min read
• Press Releases

  SonoThera™ to Present New Data at ASGCT 2025 Demonstrating the Potential of Genetic Medicine Using Targeted, Ultrasound-Mediated Delivery in Treating Duchenne Muscular Dystrophy and Hemophilia A

  May 6, 2025

   · 

  3 min read